Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
FDA endorses J&J’s Imaavy to treat rare anemia disorder
The FDA has signed off on a label expansion for Johnson & Johnson's Imaavy, approving it as a treatment for warm autoimmune hemolytic anemia.
Kevin Dunleavy
Aug 25, 2026 9:20am
Lilly covers aging and obesity in new GLP-1 access campaign
Aug 24, 2026 4:02pm
When is the new who in HCP marketing
Brought to you by
Phreesia Network Solutions
Courts reject Medicare price negotiation lawsuits from Merck, AZ
Aug 24, 2026 3:47pm
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
Hansa eyes US listing ahead of FDA verdict on Idefirix
Aug 24, 2026 2:45pm
